bullish

Mainfreight: Blue Blood Transfusion; Upgrade to OUTPERFORM

135 Views01 Nov 2022 09:21
Broker
MFT's very strong 1H23 provisional result and bullish investor day commentary highlight further customer wins, strong momentum in network development
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 17-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Forsyth Barr
New Zealand Professional Investment Services Firm
New ZealandEquity Bottom-Up
Price Chart(Sign Up to Access)
analytics-chart
  • Mainfreight: Blue Blood Transfusion; Upgrade to OUTPERFORM
    01 Nov 2022
x